Based on the long-term development in the future, the company has invested heavily in research and development. In 2004, an independent plant extract research and development center was established. R&D center and quality inspection center (QA and QC) have more than 60 professionals of all kinds, and their R&D ability is super strong. The company's R&D team includes: Guangxi Institute of Botany, China Academy of Sciences, Guangxi College of Traditional Chinese Medicine and more than five domestic research institutions to assist the company's R&D tasks for a long time; More than 20 well-known international and domestic experts formed an expert advisory group (especially: Academician Yang Shengli, member of the Presidium of China Academy of Engineering, Professor Cao Zhuan, Secretary-General of China Bioengineering Society, world-famous polyphenol expert-Dr. Ichiro Nohara (Japan), world-famous saponin expert-Dr. Jiro Nohara (Japan)); More than 10 doctors and masters in various fields form the core R&D team; More than 50 technical professionals collaborate in research and development, and fully support the research, development and application of new products and technologies. The first-class production technologies independently owned by the company, such as membrane separation technology and high-efficiency countercurrent extraction technology, and more than 20 scientific and technological achievements independently developed by the company, such as membrane separation technology of Siraitia grosvenorii, have passed the national, provincial and municipal technical achievements appraisal, and many of them have reached the international and domestic leading level.
According to the company's development strategic plan, the company will further expand its production scale, consolidate and improve its market share and industry position advantages, and strive to make the company a leading enterprise in the plant extraction industry in China. The company's shares were listed on the Shenzhen Stock Exchange on September 3, 2007 with the stock code 002 166. Accordingly, the funds raised by the company's public offering of shares will be used for standardized plant extract processing industrialization projects and technology center construction projects. After the implementation of this project, the company's production scale will be further improved, the annual processing capacity of raw materials will reach about 654.38 million tons, the degree of product serialization will be further improved, and the product quality stability and technological advancement will leap to a higher level.